Lymphocyte depleted Hodgkin lymphoma, spleen is a rare subtype of Hodgkin lymphoma characterized by a predominance of Reed-Sternberg cells and a depletion of lymphocytes. This condition is clinically significant due to its aggressive nature and poor prognosis compared to other types of Hodgkin lymphoma. Accurate coding with ICD-10 Code C81.37 is essential for proper diagnosis, documentation, medical billing, and public health reporting, ensuring that patients receive appropriate care and resources.
ICD-10 Code C81.37 specifically denotes Lymphocyte depleted Hodgkin lymphoma affecting the spleen. This code is utilized when documenting cases where the disease manifests with significant lymphocyte depletion, often leading to splenic involvement. It is crucial for healthcare providers to use this code accurately in clinical documentation and billing to reflect the severity and specific characteristics of the patient's condition.
Lymphocyte depleted Hodgkin lymphoma, spleen is a rare and aggressive form of Hodgkin lymphoma that typically presents with advanced disease at diagnosis. The etiology is not fully understood, but it is associated with immunosuppression and may progress rapidly, necessitating prompt medical intervention.
In SOAP notes, ICD-10 Code C81.37 is utilized to document the diagnosis of Lymphocyte depleted Hodgkin lymphoma affecting the spleen. This code plays a critical role in capturing the patient's symptoms, assessment findings, and treatment plans, ensuring comprehensive documentation in both acute and chronic care settings.
ICD-10 Code C81.37 connects subjective patient-reported symptoms and objective clinical findings to a formal diagnosis of Lymphocyte depleted Hodgkin lymphoma, spleen. This code is essential for ensuring continuity of care, supporting accurate billing, and meeting EHR documentation standards.
Lymphocyte depleted Hodgkin lymphoma, spleen requires urgent medical attention due to its aggressive nature. Treatment typically involves chemotherapy and may include radiation therapy depending on the stage.


HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.
Learn moreICD-10 Code C81.37 is critical in medical billing, particularly in hospital, ER, or infectious disease care settings, ensuring accurate representation of the patient's diagnosis.
| CPT Code | Description |
|---|---|
| 96413 | Chemotherapy administration, intravenous, push, single or initial substance. |
| 36415 | Collection of venous blood by venipuncture. |
| 99223 | Initial hospital care, typically 70 minutes or more. |
Common Questions About Using ICD-10 Code C81.37 for Lymphocyte depleted Hodgkin lymphoma, spleen
What are the common symptoms of Lymphocyte depleted Hodgkin lymphoma?
Common symptoms include unexplained weight loss, fever, night sweats, and swollen lymph nodes. Patients may also experience fatigue and splenomegaly.
How is Lymphocyte depleted Hodgkin lymphoma diagnosed?
Diagnosis typically involves a combination of physical examination, imaging studies, and biopsy to identify Reed-Sternberg cells in lymphoid tissue.
What treatment options are available for this condition?
Treatment usually involves chemotherapy, and in some cases, radiation therapy may be indicated. Supportive care is also essential for managing symptoms.
Is Lymphocyte depleted Hodgkin lymphoma contagious?
No, Lymphocyte depleted Hodgkin lymphoma is not contagious. It is a type of cancer that arises from lymphatic tissue and is not spread from person to person.
Clinical Notes
SOAP notes
DAP notes
AI medical notes